OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>

OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes MORE >>

OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer MORE >>

OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator MORE >>